Evidence map›Paper›PMID 38990839›Full record

ReviewPLoS neglected tropical diseases2024

Schistosomiasis diagnosis: Challenges and opportunities for elimination.

Ombeni Ally, Bernard N Kanoi, Lucy Ochola, Steven Ger Nyanjom, Clement Shiluli, Gerald Misinzo, Jesse Gitaka

Abstract readReview
In one paragraph

Review in PLoS neglected tropical diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Observational
  6. Article
  7. Rapid and Sensitive Detection ofTropical medicine and infectious disease · 2026
    Article
  8. Article
  9. Pathogens (Basel, Switzerland) · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ombeni AllyDepartment of Molecular Biology and Biotechnology, Pan African University Institute for Basic Sciences, Technology and Innovation (PAUSTI), Nairobi, Kenya.ORCID 0009-0002-4138-6598
Bernard N KanoiCentre for Research in Infectious Diseases, College of Graduate Studies and Research, Mount Kenya University, General Kago Rd, Thika, Kenya.
Lucy OcholaDepartment of Tropical and Infectious Diseases, Institute of Primate Research, Nairobi, Kenya.
Steven Ger NyanjomDepartment of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
Clement ShiluliCentre for Research in Infectious Diseases, College of Graduate Studies and Research, Mount Kenya University, General Kago Rd, Thika, Kenya.
Gerald MisinzoSACIDS Africa Center of Excellence for Infectious Diseases, Sokoine University of Agriculture, Morogoro, Tanzania.
Jesse GitakaCentre for Research in Infectious Diseases, College of Graduate Studies and Research, Mount Kenya University, General Kago Rd, Thika, Kenya.ORCID 0000-0001-7516-522X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

overviewThe roadmap adopted by the World Health Organization (WHO) for eliminating neglected tropical diseases aims to eliminate schistosomiasis, as a public health concern, by 2030. While progress has been made towards reducing schistosomiasis morbidity control in several sub-Saharan African countries, there is still more that needs to be done. Proper surveillance using accurate diagnostics with acceptable sensitivity and specificity is essential for evaluating the success of all efforts against schistosomiasis. Microscopy, despite its low sensitivity, remains the gold standard approach for diagnosing the disease. Although many efforts have been made to develop new diagnostics based on circulating parasite proteins, genetic markers, schistosome egg morphology, and their paramagnetic properties, none has been robust enough to replace microscopy. This review highlights common diagnostic approaches for detecting schistosomiasis in field and clinical settings, major challenges, and provides new and novel opportunities and diagnosis pathways that will be critical in supporting elimination of schistosomiasis.

methodsWe searched for relevant and reliable published literature from PubMed, Scopus, google scholar, and Web of science. The search strategies were primarily determined by subtopic, and hence the following words were used (schistosom*, diagnosis, Kato-Katz, antibody test, circulating antigen, POC-CCA, UCP-LF-CAA, molecular diagnostics, nucleic acid amplification test, microfluidics, lab-on a disk, lab-on chip, recombinase polymerase amplification (RPA), LAMP, portable sequencer, nanobody test, identical multi-repeat sequences, diagnostic TPPs, REASSURED, extraction free), and Boolean operators AND and/OR were used to refine the searching capacity. Due to the global public health nature of schistosomiasis, we also searched for reliable documents, reports, and research papers published by international health organizations, World Health Organization (WHO), and Center for Disease control and Elimination.

Indexed as

SchistosomiasisAnimalsDisease EradicationHumansMolecular Diagnostic TechniquesNeglected DiseasesNucleic Acid Amplification TechniquesSchistosomaSensitivity and Specificity

Identifiers

PMID38990839
PMCPMC11239039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.